Vertex to Participate in Upcoming November Investor Conferences
29 Outubro 2024 - 5:05PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced management participation in two upcoming investor
conferences.
- Dr. Reshma Kewalramani, Chief Executive Officer and President,
will participate in a fireside chat at the Guggenheim Inaugural
Healthcare Innovation Conference on Tuesday, November 12, 2024 at
9:00 a.m. ET.
- Stuart A. Arbuckle, Executive Vice President and Chief
Operating Officer, will participate in a fireside chat at the
Stifel Healthcare Conference on Tuesday, November 19, 2024 at 8:00
a.m. ET.
A live webcast of management's remarks will be available through
the Vertex website, www.vrtx.com in the "Investors" section under
the "News and Events" page. A replay of the conference webcast will
be archived on the company's website.
About Vertex Vertex is a global biotechnology company
that invests in scientific innovation to create transformative
medicines for people with serious diseases. The company has
approved medicines that treat the underlying causes of multiple
chronic, life-shortening genetic diseases — cystic fibrosis, sickle
cell disease and transfusion-dependent beta thalassemia — and
continues to advance clinical and research programs in these
diseases. Vertex also has a robust clinical pipeline of
investigational therapies across a range of modalities in other
serious diseases where it has deep insight into causal human
biology, including acute and neuropathic pain, APOL1-mediated
kidney disease, IgA nephropathy, primary membranous nephropathy,
autosomal dominant polycystic kidney disease, type 1 diabetes and
myotonic dystrophy type 1.
Vertex was founded in 1989 and has its global headquarters in
Boston, with international headquarters in London. Additionally,
the company has research and development sites and commercial
offices in North America, Europe, Australia, Latin America and the
Middle East. Vertex is consistently recognized as one of the
industry's top places to work, including 15 consecutive years on
Science magazine's Top Employers list and one of Fortune’s 100 Best
Companies to Work For. For company updates and to learn more about
Vertex's history of innovation, visit www.vrtx.com or follow us on
LinkedIn, Facebook, Instagram, YouTube and X.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241029053925/en/
Vertex Pharmaceuticals Incorporated Investors:
InvestorInfo@vrtx.com
Vertex Pharmaceuticals (NASDAQ:VRTX)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024